Evaluation of normal and cancer cell viability after exposure to bilosomes with bleomycin and ICG

<p>The project&#39;s goal is to create a combined nanocarrier for bleomycin, a drug used in ECT, and indocyanine green (ICG), a marker used in intraoperative fluorescence imaging in near-infrared. Encapsulating these substances will enhance the effectiveness of electrochemotherapy by allowing precise determination of when and where the drug is located in the tumor tissue. There were assessed cell sensitivity and therapy effectiveness using an in vitro modelon 4T1 and CHO-1 cells. </p>